(-)-epigallocatechin 3-gallate decreases expression ISO RGD:1320047 6480464 epigallocatechin gallate results in decreased expression of DTYMK mRNA CTD PMID:18851785 (1->4)-beta-D-glucan multiple interactions ISO RGD:1320048 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DTYMK mRNA CTD PMID:36331819 (S)-nicotine decreases expression ISO RGD:1320047 6480464 Nicotine results in decreased expression of DTYMK mRNA CTD PMID:16949557 1,2-dimethylhydrazine multiple interactions ISO RGD:1320048 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DTYMK mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1320048 6480464 Dinitrochlorobenzene results in increased expression of DTYMK mRNA CTD PMID:21404309 17beta-estradiol increases expression ISO RGD:1320047 6480464 Estradiol results in increased expression of DTYMK mRNA CTD PMID:16474171 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of DTYMK mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO RGD:1320047 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DTYMK mRNA CTD PMID:20823114 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO RGD:1320047 6480464 2 more ... CTD PMID:20638727 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1320048 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320048 6480464 Tetrachlorodibenzodioxin results in increased expression of DTYMK mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DTYMK mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DTYMK mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320048 6480464 Tetrachlorodibenzodioxin affects the expression of DTYMK mRNA CTD PMID:21570461 4,4'-diaminodiphenylmethane increases expression ISO RGD:1320048 6480464 4, 4'-diaminodiphenylmethane results in increased expression of DTYMK mRNA CTD PMID:18648102 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1320048 6480464 Oxazolone results in increased expression of DTYMK mRNA CTD PMID:21404309 5-fluorouracil affects response to substance ISO RGD:1320047 6480464 DTYMK affects the susceptibility to Fluorouracil CTD PMID:15067352 5-fluorouracil multiple interactions ISO RGD:1320047 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of DTYMK mRNA] CTD PMID:15016801 5-fluorouracil increases expression ISO RGD:1320047 6480464 Fluorouracil results in increased expression of DTYMK mRNA CTD PMID:15109396 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DTYMK mRNA CTD PMID:30047161 ADP multiple interactions ISO RGD:1320047 6480464 DTYMK protein binds to [N1-(4-bis(pivaloyloxymethyl)phosphinylbuten-2-yl)thymine co-treated with Adenosine Diphosphate] CTD PMID:21128666 aflatoxin B1 increases expression ISO RGD:1320048 6480464 Aflatoxin B1 results in increased expression of DTYMK mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1320047 6480464 Tretinoin results in decreased expression of DTYMK mRNA CTD PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of DTYMK mRNA CTD PMID:30047161 antirheumatic drug increases expression ISO RGD:1320047 6480464 Antirheumatic Agents results in increased expression of DTYMK mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:1320047 6480464 arsenite promotes the reaction [G3BP1 protein binds to DTYMK mRNA] CTD PMID:32406909 benzo[a]pyrene multiple interactions ISO RGD:1320048 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DTYMK mRNA] CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1320047 6480464 Benzo(a)pyrene results in increased methylation of DTYMK promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1320048 6480464 Benzo(a)pyrene results in increased expression of DTYMK mRNA CTD PMID:22228805 bisphenol A increases expression ISO RGD:1320047 6480464 bisphenol A results in increased expression of DTYMK mRNA CTD PMID:16474171 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DTYMK mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:1320047 6480464 bisphenol A results in decreased expression of DTYMK mRNA, bisphenol A results in decreased expression of DTYMK protein CTD PMID:29275510 , PMID:34186270 bisphenol A affects expression ISO RGD:1320047 6480464 bisphenol A affects the expression of DTYMK mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DTYMK mRNA CTD PMID:25181051 , PMID:32145629 Bisphenol B increases expression ISO RGD:1320047 6480464 bisphenol B results in increased expression of DTYMK protein CTD PMID:34186270 bucladesine multiple interactions ISO RGD:1320047 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DTYMK mRNA CTD PMID:20823114 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of DTYMK mRNA CTD PMID:24136188 cadmium atom decreases expression ISO RGD:1320047 6480464 Cadmium results in decreased expression of DTYMK mRNA CTD PMID:21120746 calcitriol decreases expression ISO RGD:1320047 6480464 Calcitriol results in decreased expression of DTYMK mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1320047 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DTYMK mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1320047 6480464 Carbamazepine affects the expression of DTYMK mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:1320048 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos increases expression ISO RGD:1320048 6480464 Chlorpyrifos results in increased expression of DTYMK mRNA CTD PMID:37019170 ciguatoxin CTX1B affects expression ISO RGD:1320048 6480464 Ciguatoxins affects the expression of DTYMK mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:1320047 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of DTYMK mRNA] CTD PMID:21858171 cisplatin increases expression ISO RGD:1320047 6480464 Cisplatin results in increased expression of DTYMK mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1320047 6480464 cobaltous chloride results in decreased expression of DTYMK mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1320047 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DTYMK mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1320047 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DTYMK mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1320047 6480464 Copper Sulfate results in decreased expression of DTYMK mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1320047 6480464 Cyclosporine results in decreased expression of DTYMK mRNA CTD PMID:20106945 , PMID:25562108 diazinon affects expression EXP 6480464 Diazinon affects the expression of DTYMK mRNA CTD PMID:22546817 dibutyl phthalate decreases expression ISO RGD:1320048 6480464 Dibutyl Phthalate results in decreased expression of DTYMK mRNA CTD PMID:17361019 , PMID:21266533 diclofenac affects expression ISO RGD:1320047 6480464 Diclofenac affects the expression of DTYMK mRNA CTD PMID:24752500 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of DTYMK mRNA CTD PMID:22546817 dorsomorphin multiple interactions ISO RGD:1320047 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DTYMK mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:1320047 6480464 DTYMK protein affects the susceptibility to Doxorubicin CTD PMID:18413751 finasteride increases expression EXP 6480464 Finasteride results in increased expression of DTYMK mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1320048 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DTYMK mRNA CTD PMID:22206623 furan increases methylation EXP 6480464 furan results in increased methylation of DTYMK gene CTD PMID:22079235 genistein increases expression ISO RGD:1320047 6480464 Genistein results in increased expression of DTYMK mRNA CTD PMID:16474171 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of DTYMK mRNA CTD PMID:22061828 geraniol decreases expression ISO RGD:1320047 6480464 geraniol results in decreased expression of DTYMK mRNA CTD PMID:27683099 ivermectin decreases expression ISO RGD:1320047 6480464 Ivermectin results in decreased expression of DTYMK protein CTD PMID:32959892 leflunomide decreases expression ISO RGD:1320047 6480464 leflunomide results in decreased expression of DTYMK mRNA CTD PMID:28988120 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of DTYMK mRNA CTD PMID:24136188 medroxyprogesterone acetate multiple interactions ISO RGD:1320047 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DTYMK mRNA CTD PMID:20823114 methimazole increases expression EXP 6480464 Methimazole results in increased expression of DTYMK mRNA CTD PMID:30047161 methylseleninic acid decreases expression ISO RGD:1320047 6480464 methylselenic acid results in decreased expression of DTYMK mRNA CTD PMID:12517777 N-nitrosodiethylamine increases expression ISO RGD:1320048 6480464 Diethylnitrosamine results in increased expression of DTYMK mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1320048 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DTYMK mRNA] CTD PMID:17854601 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of DTYMK mRNA CTD PMID:22546817 nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of DTYMK mRNA CTD PMID:21086188 nicotine decreases expression ISO RGD:1320047 6480464 Nicotine results in decreased expression of DTYMK mRNA CTD PMID:16949557 ozone multiple interactions ISO RGD:1320048 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DTYMK mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1320048 6480464 Acetaminophen results in increased expression of DTYMK mRNA CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DTYMK mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1320047 6480464 Acetaminophen results in increased expression of DTYMK mRNA CTD PMID:22230336 paracetamol affects expression ISO RGD:1320048 6480464 Acetaminophen affects the expression of DTYMK mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1320048 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DTYMK mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:1320047 6480464 perfluorooctanoic acid results in decreased expression of DTYMK mRNA CTD PMID:36326898 phenobarbital affects expression ISO RGD:1320047 6480464 Phenobarbital affects the expression of DTYMK mRNA CTD PMID:19159669 pirinixic acid increases expression ISO RGD:1320048 6480464 pirinixic acid results in increased expression of DTYMK mRNA CTD PMID:18301758 , PMID:23811191 piroxicam multiple interactions ISO RGD:1320047 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of DTYMK mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1320047 6480464 Piroxicam results in decreased expression of DTYMK mRNA CTD PMID:21858171 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of DTYMK mRNA CTD PMID:30047161 resveratrol increases expression ISO RGD:1320048 6480464 resveratrol results in increased expression of DTYMK protein CTD PMID:25505154 SB 431542 multiple interactions ISO RGD:1320047 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DTYMK mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1320047 6480464 sodium arsenite results in increased expression of DTYMK mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:1320047 6480464 sodium arsenite promotes the reaction [DTYMK protein binds to CAPRIN1 protein] CTD PMID:33939924 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of DTYMK mRNA CTD PMID:30047161 sunitinib decreases expression ISO RGD:1320047 6480464 Sunitinib results in decreased expression of DTYMK mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1320047 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DTYMK mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1320047 6480464 Testosterone results in decreased expression of DTYMK mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1320048 6480464 Carbon Tetrachloride results in increased expression of DTYMK mRNA CTD PMID:27339419 , PMID:31919559 titanium dioxide increases expression ISO RGD:1320048 6480464 titanium dioxide results in increased expression of DTYMK mRNA CTD PMID:23557971 , PMID:27760801 tolcapone decreases expression EXP 6480464 tolcapone results in decreased expression of DTYMK mRNA CTD PMID:24136188 toluene 2,4-diisocyanate increases expression ISO RGD:1320048 6480464 Toluene 2, 4-Diisocyanate results in increased expression of DTYMK mRNA CTD PMID:21404309 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of DTYMK mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1320048 6480464 trimellitic anhydride results in increased expression of DTYMK mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1320047 6480464 troglitazone results in decreased expression of DTYMK mRNA CTD PMID:19140230 troglitazone increases expression ISO RGD:1320048 6480464 troglitazone results in increased expression of DTYMK mRNA CTD PMID:28973697 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of DTYMK mRNA CTD PMID:24136188 tungsten increases expression ISO RGD:1320048 6480464 Tungsten results in increased expression of DTYMK mRNA CTD PMID:30912803 uranium atom affects expression ISO RGD:1320047 6480464 Uranium affects the expression of DTYMK mRNA CTD PMID:15672453 urethane decreases expression ISO RGD:1320047 6480464 Urethane results in decreased expression of DTYMK mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1320047 6480464 Valproic Acid results in decreased expression of DTYMK mRNA CTD PMID:26272509 valproic acid multiple interactions ISO RGD:1320047 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DTYMK mRNA CTD PMID:27188386 zidovudine multiple interactions ISO RGD:1320047 6480464 [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of and affects the phosphorylation of DNM1L protein more ... CTD PMID:17375075 , PMID:28683400 zidovudine affects response to substance ISO RGD:1320047 6480464 DTYMK protein affects the susceptibility to Zidovudine CTD PMID:28683400